Dr. Piraye Beim

Dr. Piraye Beim, a scientist and entrepreneur revolutionizing women’s health with innovations in ovarian biology and reproductive medicine.

Born in Turkey, Dr. Beim holds a PhD from Cornell University and conducted postdoctoral research at the University of Cambridge.

She worked at the forefront of precision medicine in oncology, conducting research at Memorial Sloan Kettering Cancer Center, and later completed a postdoctoral fellowship at Cambridge, specializing in embryology and fertility science.

In 2009, she founded Celmatix Therapeutics in 2009, one of the first FemTech companies focusing on ovarian health, longevity, and precision medicine. Under her leadership, Celmatix has developed groundbreaking therapies targeting ovarian senescence and endometriosis, while decoding the genomic drivers of ovarian function.

In 2025, she was appointed Chairperson of the Endometriosis Foundation of America. Dr. Beim has been named to several prestigious lists, including Fortune’s “Top 15 Founders Disrupting Their Industries” and Crain’s 40 Under 40.

Dr. Beim’s own experience with endometriosis drives her work in ovarian health. She is focused on developing non-hormonal treatments for conditions like endometriosis, PCOS, and age-related ovarian decline.

Now, her work is reshaping women’s health, creating solutions for conditions that have long been overlooked.